Protocol Library

Single Peptide Dosage Protocols

17+ protocols covering individual peptides. Each includes reconstitution math, dosage schedules, syringe fill lines, and inline citations.

Healing & Recovery3 protocols

BPC-157 (5 mg Vial)

Complete BPC-157 dosage protocol for the 5 mg vial. Includes injection dosing schedule and healing peptide research cycle info.

5 mg vialOnce dailySubcutaneous

BPC-157 (10 mg Vial)

Complete BPC-157 dosage protocol for the 10 mg vial. Includes injection dosing schedule and healing peptide research cycle info.

10 mg vialOnce dailySubcutaneous

TB-500 (5 mg Vial)

Complete TB-500 (Thymosin Beta-4) dosage protocol for the 5 mg vial. Covers loading phase and maintenance dosing.

5 mg vialTwice weeklySubcutaneous
Metabolic & Weight Loss5 protocols

Semaglutide (5 mg Vial)

Detailed semaglutide dosage protocol with titration schedule and weekly injection guidance for the 5 mg research vial.

5 mg vialWeeklySubcutaneous

Semaglutide (10 mg Vial)

Detailed semaglutide dosage protocol with titration schedule and weekly injection guidance for the 10 mg research vial.

10 mg vialWeeklySubcutaneous

Tirzepatide (15 mg Vial)

Tirzepatide dosage protocol for the 15 mg vial. Dual GIP/GLP-1 receptor agonist with full titration schedule and weekly injection guidance.

15 mg vialWeeklySubcutaneous

Retatrutide (20 mg Vial)

Full dosage protocol for the triple-agonist GLP-1/GIP/glucagon receptor peptide in a 20 mg vial. Includes titration schedule.

20 mg vialWeeklySubcutaneous

AOD-9604 (5 mg Vial)

AOD-9604 dosage protocol for the 5 mg vial. Modified hGH fragment (176–191) studied for selective lipolysis without affecting blood glucose or IGF-1.

5 mg vialOnce dailySubcutaneous
Growth Hormone & Performance3 protocols

Ipamorelin (5 mg Vial)

Ipamorelin dosage protocol for the 5 mg vial. Selective GH secretagogue with pulsatile dosing schedule and cycle guidance.

5 mg vial2–3× dailySubcutaneous

CJC-1295 (No DAC) (5 mg Vial)

CJC-1295 (No DAC) dosage protocol for the 5 mg vial. GHRH analogue with short half-life for pulsatile GH release.

5 mg vial2–3× dailySubcutaneous

CJC-1295 DAC (5 mg Vial)

CJC-1295 DAC dosage protocol for the 5 mg vial. Long-acting GHRH analogue with once-weekly dosing.

5 mg vialOnce weeklySubcutaneous
Hormonal & Sexual Health1 protocols

PT-141 / Bremelanotide (10 mg Vial)

PT-141 (Bremelanotide) dosage protocol for the 10 mg vial. FDA-approved melanocortin receptor agonist for HSDD.

10 mg vialAs neededSubcutaneous
Skin & Cosmetic1 protocols

GHK-Cu (50 mg Vial)

GHK-Cu (copper peptide) dosage protocol for the 50 mg vial. Includes subcutaneous and topical application guidance and cycle information.

50 mg vialOnce dailySubcutaneous/Topical
Longevity & Mitochondrial2 protocols

SS-31 / Elamipretide (5 mg Vial)

SS-31 (Elamipretide) dosage protocol for the 5 mg vial. Mitochondria-targeted tetrapeptide for cardioprotection and longevity research.

5 mg vialOnce dailySubcutaneous

Epitalon (10 mg Vial)

Epitalon dosage protocol for the 10 mg vial. Tetrapeptide telomerase activator studied for anti-aging and longevity applications.

10 mg vialOnce dailySubcutaneous
Brain Health & Nootropics1 protocols

Semax (5 mg Vial)

Semax dosage protocol for the 5 mg vial. ACTH-derived nootropic peptide with BDNF-stimulating properties. Includes intranasal dosing guidance.

5 mg vialOnce dailyIntranasal/Subcutaneous
Immune & Inflammation1 protocols

Thymosin Alpha-1 (5 mg Vial)

Thymosin Alpha-1 dosage protocol for the 5 mg vial. Immunomodulatory peptide with clinical evidence for immune enhancement and antiviral activity.

5 mg vialTwice weeklySubcutaneous